Delivery Order SPE2DB24D1205-SPE2DB25FCZML
Award Date 8/13/25
Potential Completion Date 9/4/25
Potential Value $3.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a $57,859.00 delivery order to AmerisourceBergen Drug Corp for VYEPTI 100 MG/ML Vial on August 7, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price contract, awarded without set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a $4,628.72 delivery order to AmerisourceBergen Drug Corp for VYEPTI (eptinezumab) 100 mg/ml vials, with performance at the contractor's Conshohocken, Pennsylvania location and an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order valued at $4,628.72 to AmerisourceBergen Drug Corp for VYEPTI 100 mg/mL vial on September 16, 2025, with an ultimate completion date of October 7, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VYEPTI 100 mg/ml vials valued at $1,157.18 under a firm fixed price contract. The award, issued on August 7, 2025, with an ultimate completion date of August 28, 2025, represents a competitively awarded, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $20,829.24 to AmerisourceBergen Drug Corp for the supply of VYEPTI 100 MG/ML Vial on August 4, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under...
- The Defense Logistics Agency awarded a $4,628.72 firm fixed price delivery order to AmerisourceBergen Drug Corp for VYEPTI 100 mg/mL vials, with an ultimate completion date of August 8, 2025. This non-set-aside contract was competitively awarded on July 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $69,431 firm fixed price delivery order to AmerisourceBergen Drug Corp for VYEPTI 100 mg/ml vials, with an ultimate completion date of October 6, 2025. This is a non-set-aside, competitively awarded contract for pharmaceutical supply. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and operates as a major pharmaceutical distributor providing comprehensive medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VYEPTI 100 mg/mL vials valued at $3,471.54 on August 12, 2025, with completion targeted for September 3, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The award will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. VYEPTI (eptinezumab) is a monoclonal antibody used for migraine prevention,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,471.54 firm fixed-price delivery order on September 5, 2025, for VYEPTI 100 mg/mL vial medication, with completion targeted for September 26, 2025. This is a non-set-aside competitive award issued to the Conshohocken, Pennsylvania-based pharmaceutical distributor, one of the federal government's major medical supply vendors. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery...
- The Defense Logistics Agency awarded a $5,785.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for VYEPTI 100 mg/mL vial on September 11, 2025, with an ultimate completion date of October 2, 2025. This delivery order is not set-aside and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is fulfilling this order under its...